Showing 5611-5620 of 19383 results for "".
Changing Your Outcome: Converting Bad Assets to Good
https://reachmd.com/programs/your-money-your-life-financial-advice-for-physicians/changing-your-outcome-converting-bad-assets-good/8138/If you are in your 50s and have fallen behind in building your personal wealth, your most powerful strategy to “catch up” may be converting unproductive assets into productive elements of a growing investment portfolio. Join Jim Hemphill, CERTIFIED FINANCIAL PLANNER™ and co-founder of TGS FinancialHow an EHR Can Help You Participate in MACRA
https://reachmd.com/programs/perspectives-ama/how-ehr-can-help-you-participate-macra/8368/Information for physicians about the importance of electronic health records(EHRs) to participation in MACRA.Assessing G-CSF Prophylaxis with Sacituzumab Govitecan in mTNBC
https://reachmd.com/programs/project-oncology/assessing-g-csf-prophylaxis-with-sacituzumab-govitecan-in-mtnbc/48952/Patients with metastatic triple-negative breast cancer (mTNBC) treated with sacituzumab govitecan face the risk of neutropenia, which is why proactive supportive care is essential. Recent FDA label updates and emerging clinical data highlight the importance of G-CSF prophylaxis to reduce neutropeniaOptimizing Outcomes in Endometrial Cancer: From Surgery to Recurrence Management
https://reachmd.com/programs/advances-in-womens-health/optimizing-outcomes-in-endometrial-cancer-from-surgery-to-recurrence-management/36396/Endometrial cancer treatment is continuing to evolve, with surgery guiding initial decisions and new evidence showing that adding immunotherapy significantly improves outcomes in advanced disease. But key questions remain around tailoring regimens to individual patients. Dr. Ann Klopp highlights theNew FDA Approval for AD
https://reachmd.com/series/c-suite-chats/new-fda-approval-for-ad/29911/Phil Brown, MD, JD, Dermatologic Scientific Lead at Organon, talks about the importance of a new FDA-approved topical solution for treating atopic dermatitis.Educational Accommodations for the ADHD Patient
https://reachmd.com/programs/focus-on-neurology-and-psychiatry/educational-accommodations-for-the-adhd-patient/4095/How can educational accommodations be tailored to best fit ADHD patients? What role does an appropriate psychometric assessment of an ADHD patient play in determining the best educational accommodations for that patient? Do all institutions require similar documentation? Dr. Matthew Tominey, directoMultiple Myeloma: Current Treatment Modalities
https://reachmd.com/programs/clinicians-roundtable/multiple-myeloma-current-treatment-modalities/3008/Extended survival outcomes are becoming increasingly common after a diagnosis of multiple myeloma. What are some of the therapies responsible for these advances, and how far are we extending survival? Further, we’re learning that certain combination therapies are more effective for certain patients.Depression Among Resident Physicians
https://reachmd.com/programs/the-jama-report/depression-among-resident-physicians/7862/[Read the Article] Even in the general population, people often don't want to talk about depression, which is one of the major reasons it isn't always treated properly. Depression is also a concern in the medical community, particularly affecting physicians in training known as medical residents. ANew Medication for High Cholesterol Not Cost-Effective
https://reachmd.com/programs/the-jama-report/new-medication-high-cholesterol-not-cost-effective/8332/A new study in JAMA evaluated the cost-effectiveness of PCSK9 inhibitors and how increased use might affect the U.S. healthcare system.Testosterone Therapy Neither Advances Nor Slows Down Hardening of the Arteries in Older Men with Low Testosterone Levels
https://reachmd.com/programs/the-jama-report/testosterone-therapy-neither-advances-nor-slows-down-hardening-arteries-older-men-low-testosterone/7640/[Read the Article] The popularity of testosterone supplementation among older men has increased substantially over the past decade. However, the risks and benefits of long-term administration are still unclear. A new study examined whether using testosterone supplements affected the development of a